In conclusion, bestatin inhibits the migration and proliferation of breast cancer cells by decreasing the stemness of BCSCs in vitro and in vivo, and PSA participates in the mechanism through cell cycle regulation, which following induces increased cell apoptosis and decreased cell proliferation of BCSCs. This evidence concerns the gene NPEPPS and breast carcinoma.